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Dual Regulation of NMDA Receptor Functions
by Direct Protein-Protein Interactions
with the Dopamine D1 Receptor
al., 1993), nitric oxide synthase (Sattler et al., 1999), the
production of free radicals (Lafon-Cazal et al., 1993),
and mitochondrial membrane permeability (Duchen,
2000). In addition, NMDA-mediated excitotoxicity may
depend on the local cellular environment (Sattler et al.,
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and Fang Liu1,2,5
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Centre for Addiction and Mental Health 1998) and localization of the NMDA receptor (Hard-
ingham et al., 2002).Clarke Division
2 Department of Psychiatry In addition to a wide array of extracellular agents in-
cluding Mg2, glycine, Zn2, and protons (reviewed in3 Faculty of Dentistry
University of Toronto Dingledine et al., 1999), as well as intracellular agents
such as Ca2 (Rosenmund and Westbrook, 1993), NaToronto, Ontario
M5T 1R8 Canada (Yu and Salter 1998) and calmodulin (Ehlers et al., 1996;
Wyszynski et al., 1997), NMDA receptor can also be4 Brain Research Center and Department of
Medicine regulated by protein kinases and phosphatases, which
include tyrosine kinase/phosphatases (e.g., Src, PTP,Vancouver General Hospital and University of
British Columbia and STEP) (Yu et al., 1997; Lei et al., 2002; Pelkey et al.,
2002) and serine/threonine kinases/phosphotases (i.e.,Vancouver, British Columbia
V6T 1Z3 Canada protein kinase A (PKA), protein kinase C (PKC), and
phosphatases 1/2) (Lieberman and Mody, 1994; Roche
et al., 1994; Wang et al., 1994; Westphal et al., 1999;
Greengard, 2001). Furthermore, numerous studies have
demonstrated that NMDA receptor function may be reg-Summary
ulated by G protein-coupled receptors, including D1-
like receptors, through the activation of PKA/PKC de-Dopamine D1-like receptors, composed of D1 and D5
pendent pathways (reviewed in Greengard, 2001).receptors, have been documented to modulate gluta-
Dopamine D1-like receptors contain seven transmem-mate-mediated fast excitatory synaptic neurotrans-
brane domains and preferentially couple to Gs proteinsmission. Here, we report that dopamine D1 receptors
that can activate adenylate cyclase and PKA-dependentmodulate NMDA glutamate receptor-mediated func-
pathways (Missale et al., 1998). Previous studies havetions through direct protein-protein interactions. Two
demonstrated the functional modulation of ligand-gatedregions in the D1 receptor carboxyl tail can directly
NMDA receptors by G protein-coupled D1-like receptorsand selectively couple to NMDA glutamate receptor
through classical pathways involving one or more intra-subunits NR1-1a and NR2A. While one interaction is
cellular second messengers and their downstream ef-involved in the inhibition of NMDA receptor-gated cur-
fectors such as adenylate cyclase and the phosphopro-rents, the other is implicated in the attenuation of
tein DARPP-32 (Cepeda et al., 1993; Levine et al., 1996;NMDA receptor-mediated excitotoxicity through a
Harvey and Lacey, 1997; Blank et al., 1997; Snyder etPI-3 kinase-dependent pathway.
al., 1998; Cepeda and Levine, 1998). Recently, direct
protein-protein coupling has also been shown to enableIntroduction
functional crosstalk between ligand-gated GABAA and
G protein-coupled dopamine D5 receptors (Liu et al.,NMDA (N-methyl-D-aspartate) type glutamate receptors
2000), opening the possibility that other neurotransmit-are highly permeable to calcium (Ca2) and play an im-
ter receptors, including NMDA receptors, may formportant role in the regulation of activity-dependent neu-
functional crosstalk through similar mechanisms. Here,roplasticity and excitotoxicity, which underlie many
we report two distinct direct protein-protein interactionsphysiological and pathological processes including
between the D1 and NMDA receptor and the functionallearning and memory, ethanol sensitivity, epilepsy, neu-
implications of these interactions.ronal death, and mental disorders (reviewed in Dingle-
dine et al., 1999).
NMDA receptor activation facilitates Ca2 influx, Results
which under pathological conditions can result in excito-
toxicity. The “calcium overload” hypothesis is the promi- D1 and NMDA Receptors Form a Complex
through the Carboxyl Tailsnent theory explaining NMDA-mediated excitotoxicity
(Choi, 1995). The molecular mechanisms underlying To determine the existence of D1:NMDA receptor com-
plexes, we examined if NMDA receptors can coimmuno-NMDA-mediated excitotoxicity involve many Ca2-regu-
lated processes in the cell including activations of prote- precipitate with D1 receptors in rat hippocampal tissue.
As depicted in Figure 1A, NMDA receptor NR1 and NR2Aases (Brorson et al., 1995), endonucleases (Zeevalk et
subunits coimmunoprecipitate with D1 receptors sug-
gesting a physical interaction between D1 and NMDA5 Correspondence: f.liu.a@utoronto.ca
receptors. In contrast, the1 subunit of GABAA receptor,6 These authors contributed equally to this work.
7 Deceased. which has been shown to coimmunoprecipitate with the
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Figure 1. Association of D1 and NMDA Re-
ceptors in Rat Brain and In Vitro
(A) Coimmunoprecipitation of hippocampal
NMDA receptor NR1 and NR2A subunits, but
not the GABAA receptor 1 subunit, by D1 Ab
(antibody).
(B) Western blots of hippocampal NR1 sub-
unit (top), NR2A subunit (bottom) after affinity
precipitation by GST-D1CT, but not by GST-
D5CT or GST alone.
(C) Western blots of hippocampal D1 recep-
tors after affinity precipitation by GST-NR1-
1aCT, GST-NR2ACT, but not by GST-NR2BCT or
GST alone.
(D) Blot overlay assay depicting the direct
binding of [35S]-D1CT to the GST-NR1-1aCT,
GST-NR2ACT.
(E) Direct binding of the [35S]-NR1-1aCT (top),
[35S]-NR2ACT (bottom) to GST-D1CT. GST was
used as control.
(F) Top: schematic representation of the gen-
erated D1-t1; D1-t2; D1-t3 mini-genes. Amino
acid sequence D1-t2 was critical for direct
binding to NR1-1a subunit (middle); D1-t3
was critical for direct binding to NR2A subunit
(bottom).
(G) In vitro binding assay showing the block-
ade of direct binding of NR1-1a to D1 CT upon
the addition of D1-t2, but not D1-t3 peptide
(left). Blockade of direct binding of NR2A to
D1 CT upon the addition of D1-t3, but not D1-
t2 peptide (right).
(H) Coimmunoprecipitation of D1 with NR1
subunit in hippocampal neurons (top), cells
expressing D1 and NR1-1a subunit (middle)
and coimmunoprecipitation of D1 with NR2A
subunit in cells expressing D1 and NR2A sub-
unit (bottom) with or without SKF 81297 pre-
treatment. Each coimmunoprecipitation was
in parallel with Western blot analysis of the
initial levels of solubilized protein and the di-
rectly immunoprecipitated proteins. The in-
tensity of each protein band was quantified
by densitometry (software: AIS from Imaging
Research Inc). Data are representative of at
least 3 independent experiments.
D5 receptor (Liu et al., 2000), did not coimmunoprecipi- D1 receptors, as illustrated in the D1 antibody immuno-
labeled Western blot (Figure 1C).tate with the D1 receptor. The carboxyl tail (CT) of both
the D1 receptor and NR1/NR2 subunits contain putative
consensus sequences for receptor phosphorylation and Direct Protein-Protein Interactions between
D1 and NMDA Receptorspotential binding sites for various proteins important
for signaling (e.g., calcyon, PSD-95, and calmodulin; While these results demonstrate the presence of the
D1:NMDA receptor complex in rat hippocampal tissue,Missale et al., 1998; Lezcano et al., 2000; Lamey et al.,
2002; Sheng, 2001). To determine if the CT regions of it does not clarify whether the D1:NMDA receptor com-
plex is formed through a direct interaction between D1both the D1 and NMDA receptors are involved in the
formation of D1:NMDA receptor complex, various gluta- and NMDA receptors or mediated by an indirect interac-
tion involving an accessory binding protein. Blot overlaythione-S-transferase (GST) fusion proteins, encoding
the CTs of either the D1-like receptors (GST-D1CT:A332- experiments provided in vitro evidence that D1 and
NMDA receptors can directly interact with each other.T446, GST-D5CT:A360-H477) or the NR1-1a (GST-NR1-
1aCT:E834-S938), NR2A (GST-NR2ACT:D1350-V1464), NR2B GST-NR1-1aCT and GST-NR2ACT were probed with in
vitro translated [35S]-methionine labeled peptides en-(GST-NR2BCT:P1365-V1482) subunits, were prepared and
utilized in affinity purification assays. As shown in Figure coding D1 CT sequences ([35S]-D1CT). As shown in Figure
1D, the [35S]-D1CT probe bound with both GST-NR1-1aCT1B, GST-D1CT, but not GST-D5CT or GST alone, precipi-
tated solubilized hippocampal NR1 and NR2A subunits and GST-NR2ACT. The binding of [35S]-D1CT was specific,
as it did not bind with GST. Conversely, as represented inindicating that the D1 receptor can interact with NMDA
receptors through its carboxyl tail. Similarly, both the Figure 1E, [35S]-NR1-1aCT (top) and [35S]-NR2ACT (bottom)
probes bound to GST-D1CT, but failed to bind to GST.GST-NR1-1aCT and GST-NR2ACT, but not GST-NR2BCT
or GST alone, could precipitate solubilized hippocampal All blots were probed in parallel with GST antibody to
Direct Interactions between D1 and NMDA Receptors
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confirm equivalent protein loading (data not shown). and NMDA receptors confer functional relevance, we
tested if D1 receptors can modulate NMDA currentsIn order to confirm these results and to delineate the
region of the D1 CT involved in the interaction with the independent of PKA and/or PKC activation. As illus-
trated in Figure 2A, in HEK-293 cells coexpressing D1NR1-1a/2A subunits, three D1 CT GST-fusion proteins
and mini-genes (D1-t1:A357-N386, D1-t2:L387-L416, and D1- and NR1-1a/2A subunits, bath application of 10 M SKF
81297, in the presence of PKA (Rp-cAMPs, 10 M) andt3:S417-T446) were constructed (Figure 1F, top). In vitro
translated [35S]-NR1-1aCT probe bound to GST-D1-t2, PKC (staurosporine, 1 M) inhibitors, significantly re-
duced the peak and steady-state amplitudes of NMDAbut not GST-D1-t1, GST-D1-t3, or GST (Figure 1F, mid-
dle) while [35S]-NR2ACT probes bound to GST-D1-t3, but receptor currents by 28 3% and 26 6% (n 11, P
0.01), while the decay time constant was not changed.not GST-D1-t1, GST-D1-t2, or GST (Figure 1F, bottom).
Therefore, it appears that the CT of the D1 receptor Control cells expressing only NMDA receptors were not
responsive to SKF 81297 (data not shown). Moreover,contains two separate domains that can mediate direct
interactions with distinct subunits of the NMDA re- SKF produced a decrease in the slope of the current-
voltage curve with no change in the reversal potentialceptor.
To explore whether these motifs are sufficient for the (Figure 2B), suggesting that SKF-induced inhibition of
the NMDA currents were due to reductions in NMDAinteraction between the D1 and NMDA receptors, we
examined the ability of purified peptides encoding D1- receptor-activated whole-cell membrane conductance.
These data provided evidence that D1 receptor activa-t2 and D1-t3 to block the direct binding of NR1-1a:D1-
t2 and NR2A:D1-t3. As demonstrated by in vitro binding tion modulates NMDA currents through a PKA/PKC in-
dependent pathway.assays (Figure 1G), the ability of the GST-NR1-1aCT to
hybridize with [35S]-D1CT was almost completely blocked In addition, we determined that the modulation of
NMDA currents by the D1 receptor was dependent onby preincubation with the D1-t2 peptide, but not with
the D1-t3 peptide. Similarly, preincubation with the D1- the identified direct protein-protein interaction between
D1-t3 and the NR2A subunit. As illustrated in Figure 2C,t3 peptide, but not with the D1-t2 peptide, blocked the
interaction of GST-NR2ACT with [35S]-D1CT. These data in HEK-293 cells coexpressing both D1 receptor and
NR1-1a/NR2A subunits, intracellular application of D1-further support the existence of two distinct protein-
protein interactions occurring between D1 and NMDA t3 peptide significantly blocked the inhibition of NMDA
currents induced by D1 receptor activation in a concen-receptors.
tration-dependent manner. In contrast, the D1-t2 pep-
tide had no such effects, suggesting the specific involve-Agonist Regulation of D1-NMDA
ment of the D1-t3:NR2A interaction in the D1 receptorProtein-Protein Interactions
modulation of NMDA currents. The specificity of the D1-Before investigating whether the direct protein-protein
t3 peptide was further confirmed in cells coexpressinginteractions between D1 and NMDA receptors have
NMDA and D5 receptors, a D1-like receptor that canfunctional implications, we tested if D1 activation affects
the observed protein-protein interactions. As shown in also be activated by SKF 81297 (Sunahara et al., 1991).
The activation of D5 receptors also exerted an inhibitoryFigure 1H (top), in cultured rat hippocampal neurons,
D1 and NMDA receptors could associate without exoge- effect on NMDA currents; however, the D5 inhibition of
NMDA currents was not significantly affected by thenous D1 receptor agonist stimulation. Interestingly,
stimulation of D1 with the agonist SKF 81297 resulted intracellular application of the D1-t3 peptide (Figure 2C).
Furthermore, we found that SKF 81297 stimulationin a 37  5% (mean  SE, n  3) decrease in the
coimmunoprecipitation of NMDA receptors by the D1 decreased the number of NMDA receptors expressed
on cell surface, and that the SKF effect could be blockedreceptor antibody. SKF 81297 stimulation did not signifi-
cantly alter either the initial levels of solubilized protein by coexpressing the D1-t3 mini-gene, but not by the
D1-t2 mini-gene (Figure 2D), suggesting that the ob-or the levels of directly immunoprecipitated proteins.
Since the associations between D1 and NMDA receptors served D1 modulation of NMDA currents may be due
to a decrease of NMDA receptor number on the cellare mediated by two separate protein-protein interac-
tions, we next examined which interaction was affected surface.
by D1 stimulation. After SKF 81297 treatment, we found
37 2% (mean SE, n 3) decrease in the coimmuno- D1 Modulation of NMDA Current in Hippocampal
precipitation of NR1-1a subunits with the D1 receptor Culture Neurons
antibody in Cos-7 cells coexpressing D1 and NR1-1a To examine the D1:NMDA receptor interactions in a rele-
subunits (Figure 1H, middle). However, the coimmuno- vant cellular milieu, primary rat hippocampal and striatal
precipitation of the NR2A subunit with the D1 receptor neurons were utilized in parallel experiments. As shown
antibody, in Cos-7 cells coexpressing D1 and NR2A in Figure 3A, application of SKF 81297 significantly inhib-
subunits, was not affected (Figure 1H, bottom). ited the peak amplitude of NMDA receptor currents by
22  5% (n  13, p  0.01) in rat hippocampal neurons.
This effect can be fully blocked by the D1-like receptorD1 Modulation of NMDA Currents through
D1-t3:NR2A Interaction in HEK-293 Cells specific antagonist SCH-23390 (10M), but not by intra-
cellular application of GTPS (200 M), a non-hydrolyz-To date, the functional interaction between D1 and
NMDA receptors is largely thought to be mediated via able analog of GTP that inhibits receptor-mediated acti-
vation of G proteins, suggesting the D1 effects on NMDAthe activation of D1 receptor-mediated intracellular
cAMP/PKA dependent pathways (reviewed in Green- currents are not mediated through D1 receptors func-
tionally coupling to endogenous G proteins (Figure 3C).gard, 2001). Therefore, to determine whether the ob-
served direct protein-protein interactions between D1 Consistent with the data from HEK-293 cells, intracel-
Cell
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Figure 2. D1 Receptor Modulation of NMDA (NR1-1a/NR2A) Receptors-Mediated Whole-Cell Currents in HEK-293 Cells
(A) An example of L-aspartate evoked whole-cell responses in cells coexpressed with D1 and NMDA receptors before and during application
of SKF 81297.
(B) Current-voltage (I/V) relationship before (open circles) and during the application of SKF 81297 (filled circles).
(C) Summarized data indicating effects of SKF 81297 application on NMDA currents in cells coexpressed with D1 or D5 receptors without
(open bar) or with the intracellular application of D1-t2 (shaded bars) or D1-t3 (filled bars) peptides. Bars show the mean ( SE) of peak
amplitudes of NMDA currents normalized with those before SKF 81297 applications. Dashed line indicates the control level of the currents
before SKF 81297 application. *, **: P  0.05, P  0.01 (Wilcoxon test). Values in brackets indicate the number of cells tested.
(D) Summarized data indicating effects of SKF 81297 application on NMDA receptor number detected in the surface of cells without or with
coexpression of D1 receptor, D1-t2 peptide (shaded bar), or D1-t3 peptide (filled bar). Bars show means ( SE) of the ratios of colorimetric
readings under non-permeabilized conditions versus those under permeabilized conditions from cells treated with SKF 81297, normalized to
their respective control groups (dash line) treated with extracellular solution (ECS). *, **: P  0.05, P  0.01 (t test). Values in brackets indicate
the times of experiments conducted.
lular application of the D1-t3 peptide into hippocampal ing Ca2 mitochondrial influx and affecting the mito-
chondrial permeability transition pore, which is aor striatal neurons from rat or wild-type mice (D1/)
significantly reduced the observed D1 inhibition of catastrophic event for the cells that can initiate cell
death pathways (reviewed in Choi, 1995; Lipton andNMDA currents (Figures 3D–3F), while the D1-t2 peptide
did not produce any effects on the D1 modulation of Nicotera, 1998; Duchen, 2000). Therefore, attenuation
of NMDA currents may lead to protection against NMDANMDA currents (data not shown). In contract, no signifi-
cant effects of D1-t3 peptide could be found in cultured receptor-mediated excitotoxicity by reducing Ca2 in-
flux. In HEK-293 cells cotransfected with D1 and NMDAhippocampal neurons from D1 receptor-knock out
(D1/) mice (Figure 3F). The lingering SKF effects on receptors, apoptosis was induced by incubation with
NMDA currents still observed in hippocampal neurons 100 M NMDA and 10 M glycine for 1 hr followed by
with intracellular application of D1-t3 peptide or in D1/ 10 M MK-801 for 24 hr as previously described (Sattler
neurons may be due to the activation of other D1-like et al., 1999). As illustrated in Figure 4A (top), while less
receptors expressed in hippocampus, such as D5 recep- than 3% of sham-treated cells exhibited apoptosis, pre-
tors. Therefore, these results strongly suggest that the treatment with 10 M SKF 81297 significantly reduced
interaction between D1-t3 and NR2A is critical for the NMDA-induced apoptosis (NMDA: 78  3% apoptotic,
D1 mediated modulation of NMDA currents. SKF/NMDA: 37  4% apoptotic, p  0.01). There was
no significant difference in the number of apoptotic cells
between SKF-treated and non-treated cells expressingD1 Modulation of NMDA-Mediated Excitotoxicity
through D1-t2:NR1-1a Interaction only NMDA or D1 receptors (Figure 4B). Less than 3%
of non-transfected cells exhibited apoptosis upon expo-in HEK-293 Cells
Excessive NMDA receptor activation can lead to excito- sure to NMDA (data not shown). Subsequently, we
tested whether the observed D1 receptor protective ef-toxicity by inducing Ca2 overload, potentially increas-
Direct Interactions between D1 and NMDA Receptors
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Figure 3. D1 Receptor Regulation of NMDA Receptor-Mediated Whole-Cell Currents in Cultured Neurons
(A) An example of whole-cell responses mediated by NMDA receptors in hippocampal neurons before and during the application of SKF
81297.
(B) Current-voltage (I/V) relationships before (open circles) and during the application of SKF 81297 (filled circles). Bars in (C), (D), (E), and (F)
show peak NMDA current amplitudes (mean  SE) normalized by those before SKF 81297 applications.
(C) The effect of SKF 81297 application of on NMDA currents with coapplication of SCH23390 (10 M) or GTPS (200 M).
(D) The effects of SKF 81297 on NMDA currents recorded from hippocampal neurons with (filled bars) or without (open bar) intracellular
application of D1-t3 peptide. The effects of SKF 81297 application on NMDA currents recorded with (filled bar) or without (open bar) intracellular
application of D1-t3 peptide from striatal neurons (E), wild-type (D1/) or D1 receptor-deficient (D1/) mice (F). Dashed line in (C), (D), (E),
and (F) indicate the control level of NMDA currents before SKF 81297 application. *, *: P  0.05, P  0.01 (Wilcoxon test); #: P  0.05 (t test).
Values in brackets indicate the number of cells tested.
fect on NMDA receptor-mediated excitotoxicity is actu- D1I3 mini-gene in HEK-293 cell coexpressing both D1
and NMDA receptors. The D1I3 inhibitory effect on D1-ally a direct consequence of the inhibition of NMDA
currents. Surprisingly, the attenuation of NMDA-induced mediated cAMP accumulation was tested in parallel ex-
periments (data not shown). This data further supportsapoptosis by activation of the D1 receptor was not effec-
tively blocked by the coexpression of the D1-t3 mini- our contention that G proteins do not mediate the SKF
protective effects.gene (NMDA: 88  3% apoptotic, SKF/NMDA: 46.5 
8% apoptotic, p  0.01, Figure 4A, bottom). However,
the D1-t2 mini-gene completely abolished the D1 recep-
tor’s ability to attenuate NMDA receptor-mediated exci- D1 Modulation of NMDA-Mediated Excitotoxicity
in Hippocampal Culture Neuronstotoxicity (NMDA: 79 2% apoptotic, SKF/NMDA: 85
2% apoptotic, Figure 4A, middle), suggesting that the The protective effect of D1 receptor activation on
NMDA-induced apoptosis was also seen in cultured ratD1-t2:NR1-1a interaction is specifically involved in the
protective effects mediated by D1 receptor activation. hippocampal (NMDA: 92  1% apoptotic, SKF/NMDA:
62  2% apoptotic, p  0.01; Figure 5A, top), striatalTo further eliminate the possibility that the observed
D1 protective effect may be the consequence of the neurons and hippocampal neurons from wild-type mice
(Figure 5B), but not in hippocampal neurons from D1/activation of the D1-mediated cAMP dependent signal-
ing, we constructed a mini-gene encoding the third intra- mice (Figure 5B). Hippocampal neurons infected with a
recombinant adenovirus expressing the D1-t2 peptidecellular loop of the D1 receptor (D1I3), which is involved
in the physical coupling to G proteins (Bourne, 1997; resulted in a loss of the observed SKF 81297 protective
effect (NMDA: 93  0.5% apoptotic, SKF/NMDA: 93 Missale et al., 1998). Previous studies have used a poly-
peptide derived from D1I3 to uncouple the interaction 6% apoptotic, Figure 5A, middle), while neurons infected
with a D1-t3 expressing adenovirus (NMDA: 98  1%between D1 and Gds subunit to effectively antagonize
D1 receptor signaling, as indexed by D1-mediated apoptotic, SKF/NMDA: 43  4% apoptotic, p  0.01,
Figure 5A, bottom) or the wild-type adenovirus (data notcAMP accumulation (Hawes et al., 1994; Feldman et al.,
2002). Therefore, we examined the effect of D1I3 mini- shown) did not differ from non-infected neurons and
retained the SKF 81297 protective effect. The inabilitygene on D1 receptor modulation of NMDA toxicity. As
shown in Figure 4B, the D1 receptor protective effects of D1-t3 peptide to block the D1 protective effects on
NMDA induced apoptosis delineates different pathwayson NMDA induced apoptosis could not be blocked by
Cell
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Figure 4. D1 Receptor Modulation of NMDA
Receptor-Mediated Excitotoxicity in Cotran-
sfected HEK-293 Cells
(A) Immunofluorescence imaging of the co-
transfected HEK-293 cells with or without the
D1-t2 (middle) or D1-t3 (lower image) mini-
genes respectively. Cells exhibit red fluores-
cence indicating healthy cells while the apo-
ptotic cells exert green fluorescence.
(B) Bar graph summarizing the apoptosis data
(with or without SKF 81297 treatment) ob-
tained from HEK-293 cells with D1-t2, D1-t3
or D1I3 mini-genes. Data are representative of
at least 3 independent experiments. Apo-
ptotic cells were counted in 15–20 fields in
each experiment with a total cell sampling of
3000–6000.
for D1-mediated inhibition of NMDA currents and D1- with wortmannin (100 nM, 30 min) displayed apoptosis.
Furthermore, in fibroblast lines derived from wild-typemediated protection of NMDA induced excitotoxicity.
and PI-3 kinase p85/ embryos (Fruman et al., 1999)
cotransfected with D1 and NMDA receptors, activationD1 Modulation of NMDA-Mediated Excitotoxicity
through a PI-3 Kinase Dependent Mechanism of D1 receptors exhibited no protective effects on
NMDA-induced apoptosis in p85/ cells (NMDA: 99PI-3 kinases have been implicated in the regulation of
many fundamental cellular responses including prolifer- 3% apoptotic, SKF/NMDA: 97  2% apoptotic, Figure
6A, c). In contrast, D1 receptor activation effectivelyation, transformation, protection from apoptosis, super-
oxide production, cell migration, and adhesion (re- protected cells from NMDA toxicity in wild-type cells
(NMDA: 96  1% apoptotic, SKF/NMDA: 46  6% apo-viewed in Toker and Cantley, 1997). We found that
preincubation with the PI-3 kinase inhibitor wortmannin ptotic, P  0.01, Figure 6A, d). Untreated wild-type and
p85/ fibroblasts cotransfected with both D1 and(100 nM, 30 min) completely abolished the ability of the
D1 receptor to modulate NMDA-induced apoptosis in NMDA receptors showed less than 3% apoptosis. Thus,
these data demonstrated that the modulation of NMDA-HEK-293 cells cotransfected with D1 and NMDA recep-
tors (NMDA: 80  5% apoptotic, SKF/NMDA: 78  2% mediated neurotoxicity by D1 receptors is through a
PI-3 kinase-dependent mechanism.apoptotic) and hippocampal neurons (NMDA: 98  3%
apoptotic, SKF/NMDA: 98  2% apoptotic, Figure 6A, It has been shown that calmodulin (CaM), which di-
rectly binds to PI-3 kinase, plays an important role ina, b), indicating that the D1 receptor modulates NMDA-
induced apoptosis may be through a PI-3 kinase depen- the activation and accumulation of the PI-3 kinase (Joyal
et al., 1997; Fischer et al., 1998; Egea et al., 2001). Wedent mechanism. Less than 1% of the cotransfected
HEK-293 cells and the hippocampal neurons pretreated found that CaM acted as a competitive inhibitor to the
Direct Interactions between D1 and NMDA Receptors
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Figure 5. D1 Receptor Modulation of NMDA
Receptor-Mediated Excitotoxicity in Neurons
(A) Immunofluorescence imaging of both
non-infected hippocampal neurons and neu-
rons infected with recombinant D1-t2 or D1-
t3 adenovirus.
(B) Bar graph summarizing the apoptosis data
(with or without SKF 81297) obtained from
rat hippicampal and striatal neurons infected
with recombinant D1-t2 or D1-t3 adenovirus
and hippocampal neurons from D1 (/), D1
(/) mice. Data are representative of at least
3 independent experiments. Apoptotic neu-
rons (cell body) were counted in 15–20 fields
in each experiment with a total cell sampling
of 3000–6000.
observed NR1-1a:D1-t2 coupling in a concentration and which could be blocked by CaM antagonist W-13 or by
coexpressing the D1-t2 mini-gene, but not by the D1-calcium-dependent manner (Figure 6B). The agonist
stimulation of D1 receptors resulted in a dissociation t3 mini-gene (Figures 6D and 6E). Taken together, these
data provide evidence for the modulation of NMDA-of the D1:NR1 complex (Figure 1H) and promoted the
formation of NR1-1a:CaM complex. As shown in Figure mediated neurotoxicity by D1 receptors through a PI-3
kinase dependent pathway.6C (top) in Cos-7 cells coexpressing D1 and NR1-1a
subunits, SKF 81297 stimulation of the D1 receptor led
to an increased coimmunoprecipitation of the NR1-1a Discussion
subunit with CaM by 57  2% (mean  SE, n  3).
Surprisingly, we also found that SKF 81297 applications The regulation of NMDA receptors has important func-
tional consequences given the role of NMDA receptorsnot only significantly increased the association of PI-3
kinase with NR1 subunits by 62  5% (mean  SE, n  in synaptic plasticity and excitotoxicity. As illustrated in
Figure 7, we have now identified two distinct protein-3) in cotransfected Cos-7 cells and by 50 7% (mean
SE, n  3) in hippocampal neurons (Figure 6, middle protein interactions between D1 and NMDA receptors
that regulate NMDA functions. Two regions of the D1and bottom), but also increased PI-3 kinase activity,
Cell
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Figure 6. D1 Receptor Modulates NMDA-Mediated Excitotoxicity through a PI-3 Kinase Dependent Pathway
(A) Immunofluorescence imaging of cotransfected HEK-293 cells (a), hippocampal neurons (b) pretreated with 100 nM wortmannin, fibroblast
derived from p85 / (c) and wild-type (d) embryos. Data are representative of at least 3 independent experiments. Apoptotic cells (neuron
cell body) were counted in 15–20 fields in each experiment with a total cell sampling of 3000–6000.
(B) In vitro binding assay demonstrating the competition between D1-t2 and CaM for binding to the C-terminal tail of NR1-1a subunit. GST-
NR1-1aCT (10 g) was incubated with [35S]-D1-t2 in the presence of Ca2 (top) or EGTA (bottom) with increasing concentrations of CaM.
(C) Coimmunoprecipitation of CaM with NR1-1a subunit (top); NR1-1a with p85 subunit of PI-3 kinase in Cos-7 cells coexpressing D1 and
NR1-1a subunit (middle) and hippocampal neurons (bottom) with or without SKF pre-treatment. Each coimmunoprecipitation was in parallel
with Western blot analysis of the initial levels of solubilized protein and the directly immunoprecipitated proteins. The intensity of each protein
band was quantified by densitometry (software: AIS from Imaging Research, Inc). Data are representative of three independent experiments.
(D) PI-3 kinase activities in anti-p85 immunoprecipitates from Cos-7 cells expressing D1 receptor only, coexpressing D1 and NR1-1a2A
subunits, D1/NMDA receptors with D1-t2 or D1-t3 mini gene (with or without pretreatment with 10 M SKF 81297) were assayed using
phosphatidylinositol as a substrate. Lipid products were extracted and separated by TLC. Position of phosphatidylinositol 3-phosphate (PIP)
and origin of migration are indicated.
(E) D1 activation induced PI-3 kinase activity enhancement was blocked by pretreatment with calmodulin antagonist W-13 (10 M) from Cos-7
cells coexpressing D1 and NR1-1a/2A subunits.
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Figure 7. A Schematic of Direct Interactions
between NMDA and D1 Receptors
Agonist activation of D1 receptors results in
the dissociation of the D1-t2 region of the D1
receptor from the NR1 CT, allowing for the
recruitment of CaM and PI-3 kinase (p85/
p110 subunits) to the NR1 CT and subsequent
activation of PI-3 kinase dependent cell sur-
vival mechanism(s). D1 activation inhibits
NMDA currents through the D1-t3:NR2A in-
teraction by reducing the receptor membrane
expression.
receptor carboxyl tail (D1-t2, D1-t3) are associated with treatment, which is in sharp contrast to the anti-apo-
ptotic effects of PI-3 kinase dependent pathway upona specific subunit of the NMDA receptor (NR1-1a,
NR2A). More importantly, by activating a single dopa- activation of D1 receptors. Furthermore, neither D1 nor
NMDA receptors (NR1-1a/NR2A) alone was capable ofmine receptor subtype D1, each interaction can modu-
late one of two primary functional outcomes of NMDA enhancing PI-3 kinase activity with or without agonist
stimulation. Taken together with the observation thatreceptor activation: NMDA-gated currents and excito-
toxicity. the D1-t2 mini-gene can block the enhancement of PI-3
kinase activity, the data suggest the critical role of theWhole-cell patch clamp recordings from hippocam-
pal, striatal neurons, and HEK-293 cells coexpressing D1-t2:NR1-1a interaction in this process. We have dem-
onstrated the competitive binding of D1-t2 and CaM toD1 and NMDA receptors exhibited an inhibition of
NMDA-mediated currents upon D1 receptor activation the NR1-1aCT in a concentration and calcium-dependent
manner. Interestingly, agonist stimulation of D1 recep-by SKF 81297. The SKF effect could not be attributed
to either PKC or PKA activation due to the application tors, which protects cells from NMDA-mediated excito-
toxicity, leads to the uncoupling of the D1-t2:NR1-1aof inhibitors throughout the recordings. The inability of
GTPS to inhibit the SKF effect strongly suggests that complex, thereby leaving NR1-1a subunits more acces-
sible to promote the formation of the NR1-1a:CaM:PI-3D1 receptors modulate NMDA currents through a path-
way independent from G protein-mediated D1 receptor kinase complex.
Previous studies have shown that the activation ofsignaling. Furthermore, we discovered that the SKF ef-
fect was significantly reduced by the D1-t3 peptide, but CaM and PI-3 kinase depends upon Ca2 availability
(Fischer et al., 1998, Egea et al., 2001); therefore, thenot with the D1-t2 peptide. Therefore, the inhibition of
NMDA-mediated currents appeared to be specifically NR1-1a:CaM:PI-3 kinase complex formation could ide-
ally place PI-3 kinase in close proximity to NMDA recep-mediated by the D1-t3:NR2A interaction. In investigating
possible mechanisms that may underlie the effects of tor-mediated Ca2 influx, facilitated by the Ca2 sensor,
CaM. Furthermore, the NR1-1a:CaM:PI-3 kinase com-D1 receptor agonist induced reduction of NMDA cur-
rents, we have found that SKF 81297 treatment signifi- plex formation would recruit PI-3 kinases to membranes
where it can phosphorylate phosphoinositides. Thus,cantly reduced the number of NMDA receptors on the
cell surface, which was prevented by cotransfecting the Ca2 influx during NMDA receptor activation would se-
quentially activate CaM and NMDA receptor-associatedD1-t3 mini-gene. Thus, the D1 modulation of NMDA re-
ceptors may be mediated through the regulation of PI-3 kinase, and thereby activate PI-3 kinase-dependent
cell survival mechanism(s) to reduce NMDA-induced ex-NMDA receptor numbers on the cell surface, and that
the D1:NR2A coupling may play a role in the regulation citotoxicity.
Recent evidence suggests that G protein-coupled re-of NMDA receptor expression on the cell surface.
It has been generally acknowledged that excessive ceptor function may be more elaborate and involve di-
rect protein coupling to form “intra-receptor” or “inter-NMDA receptor activation can lead to excitotoxicity by
inducing Ca2 overload, potentially increasing Ca2 mi- receptor” classes of complexes. The dimerization of
GABABR1 with GABABR2, which is necessary for thetochondrial influx and affecting the mitochondrial per-
meability transition pore which can lead to cell death membrane expression of the functional receptor, along
with the dimerization of 	-opioid receptors, are exam-(reviewed in Choi, 1995; Duchen, 2000). Therefore, atten-
uation of NMDA receptor currents may lead to protection ples of intra-receptor oligomerization. Inter-receptor
oligomerization can also occur between different typesagainst NMDA receptor-mediated excitotoxicity by re-
ducing Ca2 influx. However, in our study, it appears of G protein-coupled receptors, illustrated by interac-
tions between the somatostatin receptor SSTR5 withthat the observed dopamine D1 receptor attenuation of
NMDA receptor-induced toxicity was not dependent on the dopamine D2 receptor (Rocheville et al., 2000) and
the adenosine A1 receptor with the dopamine D1 recep-the reduction of Ca2 influx but by the activation of the
PI-3 kinase. Although D1 receptor activation appears tors (Gines et al., 2000). Moreover, receptor dimerization
has not only been demonstrated within a certain familyto reduce NMDA whole-cell currents by approximately
30%, comparable inhibition of NMDA whole-cell cur- of receptors, such as the G protein-coupled receptor
family, but has also been demonstrated between differ-rents by application of 10 M AP-5 (data not shown)
does not reverse the excitotoxicity induced by NMDA ent receptor families. This report, taken together with the
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glucose: 33, CaCl2: 1.3, HEPES: 25, TTX: 0.001, glycine: 0.003 (foridentification of the direct interaction of the G protein-
neurons) or 0.03 (for transfected cells), [pH 7.35], and osmolaritycoupled dopamine D5 receptor to the ligand gated ion
310–320 mosM. Recording pipettes were made from thin-walledchannel GABAA receptor (Liu et al., 2000), provides borosilicate glass capillaries (WPI, Sarasota, FL), pulled to a diame-
examples of dimerization between different families of ter of 1–2 m at the tip with a resistance of 4–7 M
, and filled
receptors and an alternative mechanism for receptor with intracellular solution composed of (mM): CsCl: 140, BAPTA: 1,
HEPES: 10, MgCl2: 2, K-ATP: 4, staurosporine: 0.001, 10 M Rp-crosstalk. Thus, the formation of “macro-receptor” com-
cAMP: 0.01; [pH 7.25], and osmolarity 290–300 mOsm. Whole-cellplexes may facilitate both direct and indirect means to
currents were evoked by application of L-aspartate or NMDA (250regulate receptor signaling.
M) via a multi-barrel fast-step perfusion system, recoded in theIn summary, our data provides further evidence that
voltage-clamp model using Axopatch 200B amplifiers (Axon Instru-
G protein-coupled receptors can modulate ligand-gated ments, Foster City, CA) at a holding potential of 60 mV except
ion channels through the direct protein-protein interac- where indicated and analyzed with pClamp6 software (Axon Instru-
ments).tions. The two independent direct protein-protein inter-
actions between D1 and NMDA receptors provide a
Recombinant Adenovirus Construction and Infectionmechanism by which the activation of the dopamine D1
Recombinant adenoviruses were formed by cotransfecting cDNAsreceptor selectively regulates multiple NMDA receptor-
encoding the D1-t2, D1-t3 in the shuttle vector pDC315 (Microbix)mediated functions. The observed subunit specific inter-
with replication-deficient adenovirus type 5 DNA into HEK-293 cells.
actions allow for functional differentiation of hetero- The recombinant adenoviruses containing the D1-t2, D1-t3 cDNAs
meric ligand-gated ion channels that are composed of were isolated, confirmed by restriction analysis, plaque-purified,
expanded, and titered. For infection, primary hippocampal culturesmultiple subunits. Specifically, we have shown the delin-
were infected with approximately 10 to 20 plaque-forming units pereation between D1 receptor-modulation of NMDA re-
neuron [multiplicity of infection (moi)] of recombinant adenovirus inceptor currents from the protection of NMDA-mediated
500 l culture medium. Cultures were supplemented with 1.5 ml ofexcitotoxicity mediated by the recruitment of PI-3 kinase
fresh medium 1 hr after infection.
and the subsequent activation of downstream PI-3 ki-
nase dependent anti-apoptotic mechanisms. PI-3 Kinase Assay
Coimmunoprecipitations were carried out with polyclonal antibodies
Experimental Procedures to the p85 subunit of PI-3 kinase (2 g/sample; Upstate Biotech)
from Cos-7 cells expressing D1 or coexpressing D1 and NMDA
GST Fusion Proteins and Minigenes receptors. The agarose-antigen-antibody complex pellets were then
D1CT, D1-t1, D1-t2, D1-t3, NR1-1aCT, and NR2ACT cDNA-encoding washed 3 each with buffers (buffer I: PBS containing 1% NP 40;
fragments were amplified by PCR from full-length cDNA clones. All buffer II: 0.5 M LiCl, 0.1 M Tris [pH 7.5]; buffer III: 10 mM Tris [pH
5 and 3 oligo-nucleotides incorporated BamHI and EcoRI sites 7.5], 100 mM NaCl). After washing, the complex was resuspended
respectively to facilitate subcloning into pcDNA3 or pGEX4T-2. Initi- in 70 l buffer III containing 14.3 mM MgCl2 and 100 g phosphoino-
ation methionine residues and stop codons were also incorporated sitides (Sigma). The reaction was initiated by the addition of 0.88
where appropriate. GST-fusion proteins were prepared from bacte- mM ATP and 5 Ci [32P] ATP. Incubation was performed for 10 min
rial lysates as described by the manufacturer (Amersham). To con- at 37C and the reaction was stopped by the addition of 160 l of
firm appropriate splice fusion and the absence of spurious PCR CHCl3: MeOH (1:1) and 20 l of 6 M HCl. Lipids were extracted
generated nucleotide errors, all constructs were resequenced. and spotted onto silica gel TLC plates. Spots corresponding to
phosphatidylinositol 3-phosphate were detected by autoradiogra-
phy and identified based on their comigration with a knownIn Vitro Binding Assays
GST-NR1-1aCT, GST-NR2ACT, or GST (10 g) alone was incubated standard.
with [35S]-D1CT probe in the presence or absence of D1-t2 or D1-t3
peptide for 4 hr at RT. The beads were then washed six times Cell-ELISA Assays
with tissue homogenizing buffer and eluted with 10 mM glutathione. Cell-ELISA assays (colorimetric assays) were done essentially as
Eluates were separated by SDS-PAGE and visualized by autoradiog- previously described (Man et al., 2000). In brief, the same density of
raphy. HEK-293 cells cotransfected with cDNAs encoding various receptor
constructs were treated with SKF-81297 and fixed in 4% paraformal-
dehyde for 10 min in the absence (non-permeant conditions) orApoptosis Detection and Fluorescence Microscopy
Apoptosis detection and fluorescence microscopy were essentially the presence (permeant conditions) of 1% Triton X-100. Cells were
incubated with a monoclonal antibody against Flag epitope (Sigma;performed as previously described (Lee et al., 2001). Briefly, HEK-
293 cells coexpressing D1, NR1-1a/2A subunits, or where indicated, 1 g/ml to detect the Flag epitope inserted into the N terminus of
NR1 subunit) for the purpose of labeling the receptors on the cellwere treated for 20 min with either 10 M SKF 81297 or control
vehicle followed by the induction of apoptosis as previously de- surface under non-permeabilized conditions or the entire receptor
pool under permeabilized conditions. After incubation with corre-scribed (Sattler et al., 1999). Apoptotic cells were detected using
the ApoAlert MitoSensor Kit (Clontech), which detects alterations sponding HRP-conjugated secondary antibodies, HRP substrate
OPD was added to produce a color reaction that was stopped within mitochondrial membrane potentials upon induction of apoptosis
(Green and Reed, 1998). After treatment with the ApoAlert Mito- 3N HCl. The rate of cell surface expression of NR1 was presented
as the ratio of colorimetric readings under non-permeabilized condi-Sensor reagent for 20 min at 37C, cells were subsequently exam-
ined under a fluorescence microscope (Leica DM1RB) with com- tions to those under permeabilized conditions and then normalized
to their respective control groups. Analysis was done using at leastputer image capture capability. The proportion of healthy to
apoptotic cells was quantified using image capture software (MCID 6–12 separate dishes in each group.
Coimmunoprecipitation, affinity pull-down, blot overlay assay,5.1, Imaging Research Inc.) with the capacity for automatic target
detection, identifying fluorescing images through defined optical and Western blot analyses were performed as previously described
in our group (Liu et al., 2000).density and spatial criteria parameters.
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